CrushSCI.com
233Average days
225.5Median days
102Fastest days
408Longest days
1302025 publications

Paper Review Records

All Paper Review Records

20 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

408 days

Nicotinamide mononucleotide potentiates the anti-tumor efficacy of CAR-NK cell therapy targeting MSLN in ovarian cancer

Authors
Xin Ouyang; Xiaotong Deng; Qizhao Wang; Minghui Chu; Xinyu Wei; Mengting Wang; Chunming Xiang; Peng Zhang; Zhe Sun; Shijun Shen; Yao XuShow moreShow less
Affiliations
1. Institute of Biology and Medicine, College of Life Science and Health, Wuhan University of Science and Technology, Wuhan, China; 2. Department of Hepatopancreatobiliary and Minimally Invasive Surgery, the People’s Hospital of Lincang, Lincang, China; 3. Department of General Surgery, Taihe Hospital, Hubei University of Medicine, Shiyan, China; 4. College of Biotechnology, Tianjin University of Science and Technology, Tianjin, China; 5. College of Biological and Chemical Engineering, Qilu Institute of Technology, Jinan, ChinaShow moreShow less
Source PDF DOI Publisher page
232 days

LncRNA PCAT7 drives tumorigenesis and glycolytic reprogramming in breast cancer via the ceRNA-mediated miR-204-5p/RUNX2 axis

Authors
Pengxiang Zhu; Wei Wu; Yining Han; Zhihan Yao; Rongxuan Xu; Xiaofeng LiShow moreShow less
Affiliations
1. Department of Epidemiology and Health Statistics, Dalian Medical University, Dalian, ChinaShow moreShow less
Source PDF DOI Publisher page
288 days

Cancer-associated KBTBD4 mutations induce differentiation defects and confer a unique therapeutic vulnerability

Authors
Rohit Sivaprasad; Kristijonas Žemaitis; David Linfeldt; Sudip Ghosh; Anne de Snaijer; Mattias Magnusson; Fredrik Ek; Jenny Hansson; Agatheeswaran SubramaniamShow moreShow less
Affiliations
1. Division of Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund, Sweden; 2. Department of Experimental Medical Science, Lund Stem Cell Center, Lund University, Lund, Sweden; 3. Chemical Biology & Therapeutics, Lund University, Lund, SwedenShow moreShow less
Source PDF DOI Publisher page
139 days

CLK3 regulates tumor angiogenesis by modulating HIF1α ubiquitination

Authors
Jing Shen; Wen Zhang; Zhiqiang Chu; Lei Zhu; Yan Feng; Xuling SunShow moreShow less
Affiliations
1. Department of Scientific Research, The First Affiliated Hospital of Shihezi University, Shihezi, PR China; 2. Department of Gastrointestinal Surgery, The First Affiliated Hospital of Shihezi University, Shihezi, PR China; 3. Department of Gastroenterology, People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China; 4. Xinjiang Clinical Research Center for Digestive Diseases, Urumqi, PR ChinaShow moreShow less
Source PDF DOI Publisher page
219 days

HOXC11 promotes head and neck squamous cell carcinomas (HNSCC) progression by regulating SPHK1 through the Wnt signaling pathway

Authors
Jing Zhang; Qionghui Wu; Jingyuan Liu; Shisheng LiShow moreShow less
Affiliations
1. Department of Stomatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; 2. School of Stomatology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; 3. Hubei Province Key Laboratory of Oral and Maxillofacial Development and Regeneration, Wuhan, China; 4. Department of Otorhinolaryngology, Head and Neck Surgery, the Second Xiangya Hospital, Central South University, Changsha, ChinaShow moreShow less
Source PDF DOI Publisher page
184 days

Glypican-3-targeted therapy in hepatocellular carcinoma: biological insights and therapeutic strategies

Authors
Na Li; Shurong Li; Peng Cao; Mengfan Tang; Junfeng Zhang; Wei Zhang; Jinfeng Liu; Chunping Ye; Dan Wu; Xixi Li; Li Dai; Xianglin ZuoShow moreShow less
Affiliations
1. Department of Immunology, School of Medicine, Nanjing University of Chinese Medicine, Nanjing, China; 2. School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China; 3. Department of Obstetrics and Gynecology, Nanjing Women and Children’s Healthcare Hospital, Women’s Hospital of Nanjing Medical University, Nanjing, China; 4. Department of Pathogen Biology, School of Medicine, Nanjing University of Chinese Medicine, Nanjing, China; 5. Department of Basic Medical Sciences, Jiangsu Medical College, Yancheng, China; 6. Biobank of Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, PR ChinaShow moreShow less
Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.